{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:25:15Z","timestamp":1794561915521,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","award":["23 K07316"],"award-info":[{"award-number":["23 K07316"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymgme.2026.110143","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:45:20Z","timestamp":1778759120000},"page":"110143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Riboflavin-responsive hyperprolinemia type I with a PRODH p.Thr466Met variant: Clinical and fibroblast-based evidence"],"prefix":"10.1016","volume":"148","author":[{"given":"Jun","family":"Kido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishin","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2026.110143_bb0005","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/7777","article-title":"The gene encoding proline dehydrogenase modulates sensorimotor gating in mice","volume":"21","author":"Gogos","year":"1999","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.ymgme.2026.110143_bb0010","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1021\/acschembio.1c00427","article-title":"Photoinduced covalent irreversible inactivation of proline dehydrogenase by S-heterocycles","volume":"16","author":"Campbell","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ymgme.2026.110143_bb0015","unstructured":"J.M. Phang, A.H. Chien-an, D. Valle, Disorders of proline and hydroxyproline metabolism. in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease. Vol. II. (8th ed.) McGraw-Hill (pub.) New York, 2001. pp. 1820-1838."},{"issue":"8","key":"10.1016\/j.ymgme.2026.110143_bb0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/088307380101600820","article-title":"Is hyperprolinemia type I actually a benign trait? Report of a case with severe neurologic involvement and vigabatrin intolerance","volume":"16","author":"Humbertclaude","year":"2001","journal-title":"J. Child Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110143_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.40.1.e7","article-title":"The severe form of type I hyperprolinaemia results from homozygous inactivation of the PRODH gene","volume":"40","author":"Jacquet","year":"2003","journal-title":"J. Med. Genet."},{"issue":"9","key":"10.1016\/j.ymgme.2026.110143_bb0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.braindev.2007.01.008","article-title":"Early neurological phenotype in 4 children with biallelic PRODH mutations","volume":"29","author":"Afenjar","year":"2007","journal-title":"Brain Dev."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110143_bb0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/YPG.0b013e3282f08a3d","article-title":"Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation","volume":"18","author":"Di Rosa","year":"2008","journal-title":"Psychiatr. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110143_bb0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1620\/tjem.151.465","article-title":"Clinical, biochemical and enzymatic studies in type I hyperprolinemia associated with chromosomal abnormality","volume":"151","author":"Oyanagi","year":"1987","journal-title":"Tohoku J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110143_bb0045","first-page":"81","article-title":"A case of type I hyperprolinemia associated with photogenic epilepsy","volume":"23","author":"Ishikawa","year":"1991","journal-title":"No To Hattatsu"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110143_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41439-021-00159-5","article-title":"Hyperprolinemia type I caused by homozygous p.T466M mutation in PRODH","volume":"8","author":"Hama","year":"2021","journal-title":"Hum Genome Var"},{"issue":"6","key":"10.1016\/j.ymgme.2026.110143_bb0055","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12098-021-03744-2","article-title":"Antioxidant therapy in a patient with hyperprolinemia type 1 presenting with mild neuromotor retardation and speech disturbance","volume":"88","author":"Ersoy","year":"2021","journal-title":"Indian J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110143_bb0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.freeradbiomed.2007.10.054","article-title":"Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stress","volume":"44","author":"Krishnan","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ymgme.2026.110143_bb0065","article-title":"The toxic effects of aflatoxin B1 and aflatoxin M1 on kidney through regulating L-proline and downstream apoptosis","volume":"2018","author":"Li","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110143_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1086\/428142","article-title":"Functional consequences of PRODH missense mutations","volume":"76","author":"Bender","year":"2005","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2026.110143_bb0075","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1073\/pnas.042700699","article-title":"Genetic variation at the 22q11 PRODH2\/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia","volume":"99","author":"Liu","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1 Suppl","key":"10.1016\/j.ymgme.2026.110143_bb0080","doi-asserted-by":"crossref","first-page":"218S","DOI":"10.1093\/jn\/136.1.218S","article-title":"Structure of the blood\u2013brain barrier and its role in the transport of amino acids","volume":"136","author":"Hawkins","year":"2006","journal-title":"J. Nutr."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110143_bb0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.celrep.2016.09.029","article-title":"Cytosolic accumulation of L-proline disrupts GABA-ergic transmission through GAD blockade","volume":"17","author":"Crabtree","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110143_bb0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/hmg\/ddl443","article-title":"Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome","volume":"16","author":"Raux","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.ymgme.2026.110143_bb0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/humu.21296","article-title":"Type I hyperprolinemia: genotype\/phenotype correlations","volume":"31","author":"Guilmatre","year":"2010","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ymgme.2026.110143_bb0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.celrep.2016.09.029","article-title":"Cytosolic accumulation of L-proline disrupts GABA-ergic transmission through GAD blockade","volume":"17","author":"Crabtree","year":"2016","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.ymgme.2026.110143_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000252","article-title":"Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function","volume":"4","author":"Kempf","year":"2008","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110143_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1523\/JNEUROSCI.19-01-00021.1999","article-title":"The mammalian brain high-affinity L-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation of excitatory nerve terminals in rat forebrain","volume":"19","author":"Renick","year":"1999","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110143_bb0115","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/7777","article-title":"The gene encoding proline dehydrogenase modulates sensorimotor gating in mice","volume":"21","author":"Gogos","year":"1999","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110143_bb0120","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/jimd.12384","article-title":"Long-term outcome of urea cycle disorders: report from a nationwide study in Japan","volume":"44","author":"Kido","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110143_bb0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jimd.12483","article-title":"Clinical manifestation and long-term outcome of citrin deficiency: report from a nationwide study in Japan","volume":"45","author":"Kido","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110143_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109185","article-title":"The current social status in adult patients with urea cycle disorders in Japan","volume":"145","author":"Kido","year":"2025","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2026.110143_bb0135","article-title":"The status of adult patients with citrin deficiency in Japan: a report from the nation-wide study","volume":"146","author":"Kido","year":"2025","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110143_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s004390050589","article-title":"A human homologue of the Drosophila melanogaster sluggish-a (proline oxidase) gene maps to 22q11.2, and is a candidate gene for type-I hyperprolinaemia","volume":"101","author":"Campbell","year":"1997","journal-title":"Hum. Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226004269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:23:39Z","timestamp":1794558219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226004269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1096719226004269"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110143","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Riboflavin-responsive hyperprolinemia type I with a PRODH p.Thr466Met variant: Clinical and fibroblast-based evidence","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110143"}}